FILTER

Refine your search with the following facets to narrow down your results.

2,769 Current news about the topic medicine

image description

Pediatric oncology: Scientists discover new Achilles heel of leukemia cells

New, unforeseen possibility in the fight against blood cancer

22-Nov-2023 - Leukemia is the most common type of cancer in children. Treatment involves intensive chemotherapy, which has severe side effects due to its non-specific mode of action. A team from the Department of Pediatrics and the Institute for Experimental Pediatric Hematology and Oncology at Goethe ...

acute myeloid leukemia blood cells cancer +3
image description

Using computer game technology to develop new materials and new active substances against diseases

Bringing molecular relationships to the big screen of virtual reality

16-Nov-2023 - Bio-chemical research is increasingly dependent on accurate computer modeling and analysis. This requires different disciplines such as natural sciences, computer science and engineering to work hand in hand. A research group has been established at Bonn-Rhein-Sieg University of Applied Sciences ...

3D modelling Active ingredient research biochemistry +6
image description

Evotec and Dewpoint Therapeutics enter strategic partnership in oncology

Agreement is based on a risk-sharing arrangement followed by milestone and royalty payments to Evotec based on success of overall programmes

08-Nov-2023 - Evotec SE and Dewpoint Therapeutics announced a strategic R&D collaboration to advance Dewpoint’s leading oncology pipeline programmes of condensate modifying therapeutics (“c-mods”) to Investigational New Drug Applications (“INDs”) using Evotec’s industry-leading fully integrated data-driven ...

clinical development drug development drug discovery +2
image description

Cellectis enters into strategic collaboration and investment agreement with AstraZeneca

Cellectis to receive up to $245M in cash, with potential for additional milestones, plus tiered royalties

03-Nov-2023 - Cellectis announced it has entered into (i) a Joint Research Collaboration Agreement (the “Collaboration Agreement”, (ii) an investment agreement relating to an initial equity investment of $80M, and (iii) a memorandum of understanding (the “MOU”) relating to an additional equity investment of ...

cell therapies gene editing gene therapy +3
image description

Merck Strengthens Oncology Pipeline Through Strategic Partnership with Hengrui

Agreement represents strong strategic fit that leverages the company’s internal DNA damage response expertise and in-house ADC capabilities

02-Nov-2023 - Merck announced a strategic collaboration with Jiangsu Hengrui Pharmaceuticals Co. Ltd. (Hengrui). The partnership includes an exclusive license worldwide (ex-China) to develop, manufacture and commercialize Hengrui’s next-generation potent and selective PARP1 (poly (ADP-ribose) polymerase 1) ...

antibody-drug conjugate cancer DNA damage +3
image description

Long COVID makes thinking slower

Objective evidence for mental fatigue

31-Oct-2023 - Characteristic of the attention and concentration problems in Long COVID is slowed information processing. With this result, neuropsychological studies of the University Hospital Jena can objectively prove the cognitive impairment often reported by affected persons. This also provides a target ...

long covid neurological diseases neurology +1
image description

BioCopy and YUMAB announce partnership to fight cancer

The development of highly specific T-cell engagers directed against pHLA tumor targets will be quick and easy

26-Oct-2023 - The greatest challenge in oncology today is to destroy cancer cells as precisely and accurately as possible without affecting healthy tissue. The focus is on short protein sequences (peptides) presented on the surface of tumor cells by an HLA protein. These pHLA complexes represent attractive ...

antibodies cancer immunotherapies +2
image description

Start-up competition m4 Award announces winners

2.5 million euros for five research teams from Bavaria

26-Oct-2023 - The five winners of this year's m4 Award pre-founding competition have been announced. Each winning team will receive 500,000 euros for their project to solve urgent medical challenges. The award was announced by BioM together with the Bavarian State Ministry of Economic Affairs, Regional ...

biomedicine bioprinting diagnostic tests +7
image description

Is the Genie Out of the Bottle? Can you trust ChatGPT in scientific writing?

Differences between veterinary articles difficult to determine

23-Oct-2023 - Since its launch in November 2022, ChatGPT, a state-of-the-art language model developed by OpenAI, L.L.C. in San Francisco, CA, USA, has garnered the attention of the scientific community. As debates about ChatGPT’s impact on every aspect of academia surge worldwide, a team from the University of ...

artificial intelligence neurology veterinary medicine
image description

Mogrify extends Series A financing to $46 million USD

The Company’s pipeline aims to address degenerative diseases of the eye, ear and pancreas via direct in vivo restoration of clinically valuable cell types

10-Oct-2023 - Mogrify Limited, a biopharmaceutical company transforming the lives of patients through a novel class of in vivo reprogramming therapies, announced an additional $10 million USD closing of its Series A financing, bringing the total raised to $46 million USD in this round. The funding will support ...

diabetes hearing loss regenerative medicine +1